vs
COPT DEFENSE PROPERTIES（CDP）与IDEAYA Biosciences, Inc.（IDYA）财务数据对比。点击上方公司名可切换其他公司
IDEAYA Biosciences, Inc.的季度营收约是COPT DEFENSE PROPERTIES的1.1倍（$207.8M vs $197.4M），IDEAYA Biosciences, Inc.净利率更高（57.4% vs 20.0%，领先37.4%），COPT DEFENSE PROPERTIES自由现金流更多（$288.9M vs $142.2M）
COPT Defense Properties是一家专业房地产投资信托基金，重点投资写字楼物业，资产主要布局于华盛顿大都会区的近郊区域，核心租户为美国政府及国防军工行业企业。截至2024年12月31日，公司旗下共持有164栋写字楼，总面积达1650万平方英尺，同时运营31个单租户数据中心，总面积590万平方英尺。
IDEAYA Biosciences是一家临床阶段生物技术企业，专注于肿瘤学领域，研发针对基因定义癌症的靶向疗法及合成致死治疗方案，推进多肿瘤类型的候选药物管线开发，与行业伙伴合作提升全球创新癌症治疗方案的可及性。
CDP vs IDYA — 直观对比
营收规模更大
IDYA
是对方的1.1倍
$197.4M
净利率更高
IDYA
高出37.4%
20.0%
自由现金流更多
CDP
多$146.7M
$142.2M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $197.4M | $207.8M |
| 净利润 | $39.4M | $119.2M |
| 毛利率 | — | — |
| 营业利润率 | 19.9% | 52.2% |
| 净利率 | 20.0% | 57.4% |
| 营收同比 | 7.6% | — |
| 净利润同比 | 8.0% | 330.1% |
| 每股收益（稀释后） | $0.32 | $1.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CDPIDYA
| Q4 25 | $197.4M | — | ||
| Q3 25 | $188.8M | $207.8M | ||
| Q2 25 | $189.9M | — | ||
| Q1 25 | $187.9M | — | ||
| Q4 24 | $183.4M | — | ||
| Q3 24 | $189.2M | $0 | ||
| Q2 24 | $187.3M | $0 | ||
| Q1 24 | $193.3M | $0 |
净利润CDPIDYA
| Q4 25 | $39.4M | — | ||
| Q3 25 | $43.7M | $119.2M | ||
| Q2 25 | $40.2M | — | ||
| Q1 25 | $36.2M | — | ||
| Q4 24 | $36.5M | — | ||
| Q3 24 | $37.4M | $-51.8M | ||
| Q2 24 | $36.4M | $-52.8M | ||
| Q1 24 | $33.7M | $-39.6M |
营业利润率CDPIDYA
| Q4 25 | 19.9% | — | ||
| Q3 25 | 22.5% | 52.2% | ||
| Q2 25 | 21.0% | — | ||
| Q1 25 | 19.1% | — | ||
| Q4 24 | 19.7% | — | ||
| Q3 24 | 19.8% | — | ||
| Q2 24 | 19.4% | — | ||
| Q1 24 | 17.5% | — |
净利率CDPIDYA
| Q4 25 | 20.0% | — | ||
| Q3 25 | 23.2% | 57.4% | ||
| Q2 25 | 21.1% | — | ||
| Q1 25 | 19.3% | — | ||
| Q4 24 | 19.9% | — | ||
| Q3 24 | 19.8% | — | ||
| Q2 24 | 19.4% | — | ||
| Q1 24 | 17.4% | — |
每股收益（稀释后）CDPIDYA
| Q4 25 | $0.32 | — | ||
| Q3 25 | $0.37 | $1.33 | ||
| Q2 25 | $0.34 | — | ||
| Q1 25 | $0.31 | — | ||
| Q4 24 | $0.31 | — | ||
| Q3 24 | $0.32 | $-0.60 | ||
| Q2 24 | $0.31 | $-0.68 | ||
| Q1 24 | $0.29 | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $275.0M | $786.9M |
| 总债务越低越好 | $2.8B | — |
| 股东权益账面价值 | $1.5B | $1.1B |
| 总资产 | $4.7B | $1.2B |
| 负债/权益比越低杠杆越低 | 1.83× | — |
8季度趋势，按日历期对齐
现金及短期投资CDPIDYA
| Q4 25 | $275.0M | — | ||
| Q3 25 | $23.7M | $786.9M | ||
| Q2 25 | $21.3M | — | ||
| Q1 25 | $24.3M | — | ||
| Q4 24 | $38.3M | — | ||
| Q3 24 | $34.5M | $920.0M | ||
| Q2 24 | $100.4M | $701.7M | ||
| Q1 24 | $123.1M | $698.8M |
总债务CDPIDYA
| Q4 25 | $2.8B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.4B | — | ||
| Q1 25 | $2.4B | — | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | — | ||
| Q1 24 | $2.4B | — |
股东权益CDPIDYA
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | $1.1B | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.5B | $1.2B | ||
| Q2 24 | $1.5B | $931.7M | ||
| Q1 24 | $1.5B | $935.3M |
总资产CDPIDYA
| Q4 25 | $4.7B | — | ||
| Q3 25 | $4.4B | $1.2B | ||
| Q2 25 | $4.3B | — | ||
| Q1 25 | $4.3B | — | ||
| Q4 24 | $4.3B | — | ||
| Q3 24 | $4.2B | $1.2B | ||
| Q2 24 | $4.2B | $973.7M | ||
| Q1 24 | $4.2B | $961.5M |
负债/权益比CDPIDYA
| Q4 25 | 1.83× | — | ||
| Q3 25 | 1.62× | — | ||
| Q2 25 | 1.63× | — | ||
| Q1 25 | 1.62× | — | ||
| Q4 24 | 1.60× | — | ||
| Q3 24 | 1.61× | — | ||
| Q2 24 | 1.61× | — | ||
| Q1 24 | 1.63× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $309.9M | $142.2M |
| 自由现金流经营现金流 - 资本支出 | $288.9M | $142.2M |
| 自由现金流率自由现金流/营收 | 146.4% | 68.4% |
| 资本支出强度资本支出/营收 | 10.7% | 0.0% |
| 现金转化率经营现金流/净利润 | 7.87× | 1.19× |
| 过去12个月自由现金流最近4个季度 | $501.5M | $13.5M |
8季度趋势，按日历期对齐
经营现金流CDPIDYA
| Q4 25 | $309.9M | — | ||
| Q3 25 | $68.6M | $142.2M | ||
| Q2 25 | $87.9M | — | ||
| Q1 25 | $72.1M | — | ||
| Q4 24 | $331.0M | — | ||
| Q3 24 | $65.1M | $-49.2M | ||
| Q2 24 | $93.8M | $-32.9M | ||
| Q1 24 | $71.0M | $-43.8M |
自由现金流CDPIDYA
| Q4 25 | $288.9M | — | ||
| Q3 25 | $62.9M | $142.2M | ||
| Q2 25 | $84.5M | — | ||
| Q1 25 | $65.1M | — | ||
| Q4 24 | $299.6M | — | ||
| Q3 24 | $61.0M | $-49.7M | ||
| Q2 24 | $88.4M | $-33.9M | ||
| Q1 24 | $57.9M | $-45.1M |
自由现金流率CDPIDYA
| Q4 25 | 146.4% | — | ||
| Q3 25 | 33.3% | 68.4% | ||
| Q2 25 | 44.5% | — | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 163.3% | — | ||
| Q3 24 | 32.3% | — | ||
| Q2 24 | 47.2% | — | ||
| Q1 24 | 30.0% | — |
资本支出强度CDPIDYA
| Q4 25 | 10.7% | — | ||
| Q3 25 | 3.0% | 0.0% | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 17.1% | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | 2.9% | — | ||
| Q1 24 | 6.8% | — |
现金转化率CDPIDYA
| Q4 25 | 7.87× | — | ||
| Q3 25 | 1.57× | 1.19× | ||
| Q2 25 | 2.19× | — | ||
| Q1 25 | 1.99× | — | ||
| Q4 24 | 9.08× | — | ||
| Q3 24 | 1.74× | — | ||
| Q2 24 | 2.58× | — | ||
| Q1 24 | 2.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
